Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A spreadsheet program for simulation of bioequivalence and bioavailability studies

H Y Abdallah1, T M Ludden

  • 1Division of Biopharmaceutics, the Food and Drug Administration, Rockville, Maryland, USA.

Computers in Biology and Medicine
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Long Noncoding RNAs MEG3, TUG1, and hsa-miR-21-3p Are Potential Diagnostic Biomarkers for Coronary Artery Disease].

Molekuliarnaia biologiia·2023
Same author

Population pharmacokinetic meta-analysis with efavirenz.

International journal of clinical pharmacology and therapeutics·2003
Same author

Methemoglobinemia induced by topical benzocaine: a warning for the endoscopist.

Endoscopy·2002
Same author

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.

Journal of pharmacokinetics and pharmacodynamics·2002
Same author

Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers.

Journal of pharmacokinetics and pharmacodynamics·2001
Same author

Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: a population pharmacokinetic study.

Journal of clinical pharmacology·2001

This study introduces an Excel spreadsheet tool for simulating bioequivalence (BE) trials. It models variability factors, aiding in the assessment of drug product performance and regulatory compliance.

Area of Science:

  • Pharmacokinetics and Pharmaceutical Sciences
  • Biostatistics and Clinical Trial Design

Background:

  • Bioequivalence (BE) trials are crucial for demonstrating therapeutic equivalence between drug products.
  • Accurate simulation of BE trials requires accounting for various sources of variability.
  • Existing simulation tools may not be readily accessible or user-friendly.

Purpose of the Study:

  • To present a user-friendly Excel-based spreadsheet program for simulating bioequivalence trials.
  • To incorporate key sources of variability affecting BE study outcomes.
  • To provide a practical tool for researchers and regulatory scientists.

Main Methods:

  • Development of a spreadsheet simulation model in Microsoft Excel for Windows.
  • Inclusion of parameters for intersubject and intrasubject variability in drug absorption and disposition.

Related Experiment Videos

  • Integration of assay precision and dose uniformity into the simulation model.

    • Main Results:

    • The simulation program generates confidence intervals and pass/fail codes for BE studies.
    • The output facilitates the assessment of bioequivalence based on simulated data.
    • An example demonstrates the impact of intrasubject variability on BE trial outcomes for identical formulations.

    Conclusions:

    • The developed Excel spreadsheet offers a practical and accessible method for simulating bioequivalence trials.
    • The tool aids in understanding the influence of variability on BE study results.
    • This simulation approach supports the design and evaluation of bioequivalence studies.